Ireland· IE-PA-PA0540/021/002
Targocid 400mg Powder and Solvent for Solution for Injection/infusion or oral solution
A teicoplanin product containing teicoplanin, registered in Ireland by Sanofi-Aventis Ireland Limited T/A SANOFI. The same ATC class is registered in 15 of our 19 countries.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
Where it is registered
Teicoplanin is registered in 15 of 19 countries.
Countries holding a registration under ATC J01XA02 (teicoplanin), each read from that country’s own register.
- This record: Ireland, from HPRA (Ireland)
- 8 of them publish a price we can compare per daily dose
Teicoplanin · ATC J01XA02
15 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
The record
At a glance
HPRA (Ireland)- Active substance
- Teicoplanin
- Manufacturer
- Sanofi-Aventis Ireland Limited T/A SANOFI
- Country
- Ireland (IE)
- ATC code
- J01XA02
- ATC class
- Teicoplanin
- Defined daily dose
- 0.4 g, P
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberPA0540/021/002
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Teicoplanin in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomTargocid 200mg powder and solvent for solution for injection vialsSanofi
- PolandTargocidDelfarma Sp. z o.o.
- CzechiaTARGOCIDSanofi s.r.o., Praha
- SpainTARGOCID 200 mg POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE Y PARA PERFUSIONSanofi Aventis S.A.
- GermanyTeicoplanin AltanAltan Pharmaceuticals S.A.
- NetherlandsTargocid 200, 200 mg poeder en oplosmiddel voor oplossing voor injectie/infusie of orale oplossingSanofi B.V.
- FranceTARGOCID 100 mg, poudre et solvant pour solution injectable/pour perfusion ou solution buvableSANOFI WINTHROP INDUSTRIE
- BelgiumTargocid 200 mgSanofi Belgium
Authorised across Europe · EMA
The same active substance is authorised in 25 EEA countries. Names it is sold under:
- Austria · Teicoplanin Accord, Teicoplanin Altan
- Belgium · Targocid, Teicoplanin Bradex
- Bulgaria · Планитек, Планицид
- Cyprus · Talinac, Teicoplanin Aptapharma
- Czechia · Targocid, Teicoplanin Aptapharma
- Germany · Teicoplanin Altan, Teicoplanin Centurion
- Denmark · Targocid, Teicoplanin Demo S.A.
- Spain · Targocid, Teicoplanina Accord
- Finland · Targocid, Teicoplanin Demo S.A.
- France · Targocid, Teicoplanine Altan
- United Kingdom (Northern Ireland) · Targocid, Teicoplanin
- Greece · Talinac, Targocid
- Croatia · Targocid, Teikoplanin Aptapharma
- Hungary · Targocid, Teicoplanin Anfarm
- Italy · Planicid, Targosid
- Luxembourg · Targocid
- Malta · Targocid, Teicoplanin Anfarm
- Netherlands · Targocid, Teicoplanin Sun
- Norway · Teicoplanin Demo S.A.
- Poland · Targocid, Teicoplanin Altan
- Portugal · Teicoplanina Accord, Teicoplanina Altan
- Romania · Targocid, Teicoplanină Aptapharma
- Sweden · Targocid, Teicoplanin Bradex
- Slovenia · Targocid, Teikoplanin Aptapharma
- Slovakia · Targocid, Teicoplanin Aptapharma
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/dbc9a28d-62be-4634-adf0-2721a36cd7ef GET /v1/drugs/dbc9a28d-62be-4634-adf0-2721a36cd7ef?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Powder and solvent for solution for injection/infusion",
"routes": [
"Intramuscular use",
"Intravenous use",
"Oral use"
],
"source": "hpra",
"atc_all": [
"J01XA",
"J01XA02"
],
"strength": null,
"pa_number": "PA0540/021/002",
"substances": [
"Teicoplanin"
],
"legal_basis": "Full application (Article 8(3) of Directive No 2001/83/EC)",
"market_info": "Marketed",
"authorised_at": "23/02/1990",
"dispensing_status": "Product subject to prescription which may not be renewed (A)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}See everything about teicoplanin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.